Literature DB >> 9812176

Successful use of long-term frozen lymphocytes for the establishment of lymphoblastoid cell lines.

S Tremblay1, E W Khandjian.   

Abstract

Mesh：

Year:  1998        PMID： 9812176     DOI： 10.1016/s0009-9120(98)00066-6

Source DB:  PubMed          Journal:  Clin Biochem        ISSN： 0009-9120            Impact factor:   3.281


× No keyword cloud information.
  10 in total

1.  Establishment of stably EBV-transformed cell lines from residual clinical blood samples for use in performance evaluation and quality assurance in molecular genetic testing.

Authors:  Susan H Bernacki; Ana K Stankovic; Laurina O Williams; Jeanne C Beck; James E Herndon; Karen Snow-Bailey; Thomas W Prior; Karla J Matteson; Linda M Wasserman; Eugene C Cole; Timothy T Stenzel
Journal:  J Mol Diagn       Date:  2003-11       Impact factor: 5.568

2.  High-potentiality preliminary selection criteria and transformation time-dependent factors analysis for establishing Epstein-Barr virus transformed human lymphoblastoid cell lines.

Authors:  I-C Chang; J-Y Wu; H-I Lu; H-W Ko; J-L Kuo; C-Y Wang; P-S Shen; S-M Hwang
Journal:  Cell Prolif       Date:  2006-12       Impact factor: 6.831

3.  A Simple Red Blood Cell Lysis Method for the Establishment of B Lymphoblastoid Cell Lines.

Authors:  Xi Liu; Chongfeng Xu; Ziyuan Duan
Journal:  J Vis Exp       Date:  2017-01-14       Impact factor: 1.355

4.  Viable mononuclear cell stability study for implementation in a proficiency testing program: impact of shipment conditions.

Authors:  Olga A Kofanova; Kristine Davis; Barbara Glazer; Yvonne De Souza; Joseph Kessler; Fotini Betsou
Journal:  Biopreserv Biobank       Date:  2014-06       Impact factor: 2.300

5.  An atypical form of erythrokeratodermia variabilis maps to chromosome 7q22.

Authors:  Thomas G Saba; Alexandre Montpetit; Andrei Verner; Pierre Rioux; Thomas J Hudson; Régen Drouin; Christian A Drouin
Journal:  Hum Genet       Date:  2004-11-25       Impact factor: 4.132

6.  Epstein-Barr virus-induced transformation of B cells for the diagnosis of genetic metabolic disorders--enumerative conditions for cryopreservation.

Authors:  A S Mello; M G Burin; K Michellin; M Viapiana; R Giugliani; J C Coelho; M E Bauer
Journal:  Cell Prolif       Date:  2006-02       Impact factor: 6.831

7.  Capacity of robot handling for Epstein-Barr virus transformation.

Authors:  I-C Chang; H-W Ko; S-M Hwang
Journal:  Cell Prolif       Date:  2009-02       Impact factor: 6.831

8.  LAMP2 as a marker of EBV-mediated B lymphocyte transformation in the study of lysosomal storage diseases.

Authors:  A S Mello; M P Goldim; J Mezzalira; C S Garcia; V V Daitx; V V Daitz; C D Castilhos; M S Viegas; O V Vieira; J C Coelho
Journal:  Mol Cell Biochem       Date:  2013-09-26       Impact factor: 3.396

9.  A minor alternative transcript of the fumarylacetoacetate hydrolase gene produces a protein despite being likely subjected to nonsense-mediated mRNA decay.

Authors:  Natacha Dreumont; Antonella Maresca; Jean-François Boisclair-Lachance; Anne Bergeron; Robert M Tanguay
Journal:  BMC Mol Biol       Date:  2005-01-07       Impact factor: 2.946

10.  A missense mutation (Q279R) in the fumarylacetoacetate hydrolase gene, responsible for hereditary tyrosinemia, acts as a splicing mutation.

Authors:  N Dreumont; J A Poudrier; A Bergeron; H L Levy; F Baklouti; R M Tanguay
Journal:  BMC Genet       Date:  2001-06-29       Impact factor: 2.797
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.